{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":45,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":45,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"7626a6004b58","filters":{"venue":"Expert Opinion on Therapeutic Patents"}},"results":[{"id":"W1982970232","doi":"10.1517/13543776.2013.780598","title":"Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005 – 2013)","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Enzyme function and inhibition","field":"Biochemistry, Genetics and Molecular Biology","cited_by":295,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"McMaster University","keywords":"Carbonic anhydrase; Pharmacology; Chlorthalidone; Chemistry; Furosemide; Diuretic; Hydrochlorothiazide; Bumetanide; Drug; Acetazolamide; Medicine; Internal medicine; Blood pressure; Enzyme; Biochemistry","authors":[{"name":"Fabrizio Carta","is_ca":false},{"name":"Claudiu T. Supuran","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0921937601477758,"gpt":0.3382070873180926,"spread":0.2460133271703168,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007130454,0.0007116921,0.00114182,0.00506135,0.0003020882,0.001162715,0.0007834892,0.0009886794,0.01556057],"category_scores_gemma":[0.002198308,0.0002280222,0.001166046,0.00574615,0.0003579418,0.001433051,0.0005083391,0.0008941104,0.002568906],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007596372,"about_ca_system_score_gemma":0.001981854,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001468083,"about_ca_topic_score_gemma":0.002239365,"domain_scores_codex":[0.9995493,0.00004931662,0.0001024317,0.00007793893,0.0001754086,0.0000454861],"domain_scores_gemma":[0.9987788,0.0005365248,0.0003501912,0.00001707808,0.0002724865,0.00004494649],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002368378,0.00007657108,0.0008137757,0.08831286,0.0002638675,0.0008631705,0.0001613582,0.0002551666,0.001539305,0.002849848,0.05334586,0.8512814],"study_design_scores_gemma":[0.00007080895,0.0002458147,0.005670023,0.04033636,0.001529859,0.004266079,0.0001993814,0.0001631599,0.0009546222,0.001629361,0.9448882,0.00004629336],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0008210263,0.9939382,0.0001668091,0.00100843,0.0002394789,0.00002751569,0.0004231007,0.00001603209,0.003359411],"genre_scores_gemma":[0.003641465,0.9943746,0.0002006195,0.0005436818,0.0002254985,0.00001669665,0.0003416036,0.000002846368,0.000652883],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01556057,"threshold_uncertainty_score":0.0520553,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2069045375","doi":"10.1517/13543776.2011.539205","title":"Signal transducer and activator of transcription 3 inhibitors: a patent review","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"STAT protein; STAT3; Regulator; In vivo; Computational biology; Small molecule; Peptidomimetic; Medicine; Cancer research; stat; Biology; Pharmacology; Signal transduction; Cell biology; Peptide; Biochemistry; Gene; Genetics","authors":[{"name":"Brent D. G. Page","is_ca":true},{"name":"Daniel P. Ball","is_ca":true},{"name":"Patrick T. Gunning","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1864480791170665,"gpt":0.3904915374547805,"spread":0.204043458337714,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003793923,0.0009476376,0.00108406,0.001607405,0.0002944343,0.0008985359,0.0007158567,0.001129432,0.009235233],"category_scores_gemma":[0.0004443666,0.0002154149,0.0005064517,0.002120804,0.0002797772,0.001221338,0.0003865359,0.00161767,0.005846906],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006423047,"about_ca_system_score_gemma":0.001098762,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008023798,"about_ca_topic_score_gemma":0.001720667,"domain_scores_codex":[0.9998528,0.00001535964,0.00001195993,0.00002268722,0.00007688825,0.00002035547],"domain_scores_gemma":[0.9998616,0.00004377888,0.0000292684,0.000004444716,0.00004272834,0.00001819009],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008363215,0.0001408448,0.0000646412,0.004676812,0.00004053252,0.0004315951,0.00003172469,0.0003163336,0.003522679,0.004006929,0.07614659,0.9105377],"study_design_scores_gemma":[0.00005527988,0.0001419469,0.0004063601,0.001304465,0.00005864876,0.00106142,0.00002125635,0.0001036006,0.0006800466,0.00144378,0.9947108,0.00001238341],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0008693007,0.9819512,0.0007239759,0.002406484,0.001350044,0.00006236864,0.0001750966,0.00004604318,0.01241552],"genre_scores_gemma":[0.002454606,0.9882457,0.0009660657,0.001242024,0.0006756067,0.00004466295,0.0002219536,0.000005854365,0.006143569],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.009235233,"threshold_uncertainty_score":0.03089494,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2068430448","doi":"10.1517/13543770802672598","title":"Recent advances in the development of NS5B polymerase inhibitors for the treatment of hepatitis C virus infection","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Hepatitis C virus research","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Hepatitis C virus; Medicine; Cirrhosis; Disease; Virus; Liver disease; Hepatitis C; Immunology; Intensive care medicine; Virology; Internal medicine","authors":[{"name":"Pierre L. Beaulieu","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1976010030924328,"gpt":0.4564261719388696,"spread":0.2588251688464369,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001073767,0.0008096228,0.001059725,0.002219055,0.0002512409,0.0007915719,0.0007765464,0.0008883926,0.004637915],"category_scores_gemma":[0.0009762225,0.0002228097,0.0005370703,0.002347108,0.000373636,0.001244987,0.000417888,0.001076204,0.002429215],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005631348,"about_ca_system_score_gemma":0.00097657,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006962591,"about_ca_topic_score_gemma":0.001424466,"domain_scores_codex":[0.9997523,0.00004593773,0.00003460756,0.0000344977,0.0001053129,0.00002734625],"domain_scores_gemma":[0.9995259,0.0002058029,0.00007602054,0.00001301222,0.0001399682,0.00003930553],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001369686,0.00009624242,0.0001632521,0.01520422,0.00009450061,0.0004142236,0.00007305555,0.0005016509,0.003989566,0.002642467,0.02473509,0.9519487],"study_design_scores_gemma":[0.00007133832,0.000310004,0.001023583,0.002927601,0.0002055074,0.001805806,0.00006414717,0.000210778,0.001771654,0.001694912,0.9898916,0.00002290132],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003561878,0.9965076,0.0002158491,0.0004317779,0.0002801237,0.00001045537,0.00001625004,0.00001125317,0.002170578],"genre_scores_gemma":[0.001364953,0.997118,0.0003368786,0.0002412557,0.0002881439,0.000007702862,0.00002878438,0.000001299087,0.0006129403],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004637915,"threshold_uncertainty_score":0.01551539,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2067881291","doi":"10.1517/13543776.2013.736494","title":"Tanshinone derivatives: a patent review (January 2006 – September 2012)","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Traditional Chinese Medicine Analysis","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Neuroprotection; Prodrug; Pharmacology; In vivo; Chemistry; Kinase; Medicine; Biochemistry; Biology","authors":[{"name":"Xiaohong Tian","is_ca":true},{"name":"Jian Wu","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3000212256577778,"gpt":0.417760204920846,"spread":0.1177389792630682,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002826322,0.0009943472,0.0009941781,0.002557146,0.0003072983,0.00078523,0.000621272,0.000755342,0.01154339],"category_scores_gemma":[0.0003990172,0.00024613,0.0005521262,0.002967883,0.0002682201,0.001146844,0.0004590321,0.000972511,0.004796651],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005397371,"about_ca_system_score_gemma":0.001062372,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001034835,"about_ca_topic_score_gemma":0.002294817,"domain_scores_codex":[0.9998747,0.00001112901,0.00001534715,0.00002233125,0.00005863419,0.00001783267],"domain_scores_gemma":[0.999878,0.00003138452,0.00003072499,0.000003782056,0.00004036029,0.00001566124],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008586171,0.00008173323,0.000104501,0.01328628,0.00006570137,0.0005153019,0.00004984915,0.0002316229,0.003533609,0.001925239,0.03451638,0.9456038],"study_design_scores_gemma":[0.00004464655,0.0001401581,0.0008400127,0.002179586,0.000145882,0.001456713,0.00004277028,0.00007021899,0.001224266,0.0007071876,0.9931312,0.0000173971],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0008955922,0.9912406,0.0002916726,0.0005182759,0.0005324673,0.00004109233,0.000143334,0.000027398,0.00630957],"genre_scores_gemma":[0.003921289,0.9907976,0.0004540226,0.000405277,0.000269367,0.0000284312,0.0002050047,0.000003715152,0.003915176],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01154339,"threshold_uncertainty_score":0.03861648,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2112661022","doi":"10.1517/13543776.2014.1000303","title":"Therapeutic uses of furin and its inhibitors: a patent review","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Cellular transport and secretion","field":"Biochemistry, Genetics and Molecular Biology","cited_by":88,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Furin; Context (archaeology); Clinical trial; Medicine; Drug discovery; Computational biology; Pharmacology; Bioinformatics; Biology; Biochemistry; Enzyme","authors":[{"name":"Frédéric Couture","is_ca":true},{"name":"Anna Kwiatkowska","is_ca":true},{"name":"Yves L. Dory","is_ca":true},{"name":"Robert Day","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1731927925268858,"gpt":0.363310240735042,"spread":0.1901174482081562,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005356271,0.0007084477,0.001117319,0.002375149,0.0003193865,0.001022979,0.0007998705,0.001105033,0.008273547],"category_scores_gemma":[0.0009083624,0.0002400837,0.0006894246,0.002047658,0.0003760008,0.001294269,0.0004795842,0.001470937,0.002558121],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006222607,"about_ca_system_score_gemma":0.001138961,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007936819,"about_ca_topic_score_gemma":0.001444011,"domain_scores_codex":[0.9997852,0.00003105134,0.00002671691,0.00003593124,0.00009627317,0.00002476476],"domain_scores_gemma":[0.9996457,0.0001817767,0.0000645879,0.00000865171,0.00007544122,0.00002378777],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006621436,0.0000692132,0.0001017294,0.01960128,0.00007683212,0.0003900469,0.00006114133,0.0003534281,0.001849499,0.005154083,0.0452566,0.92702],"study_design_scores_gemma":[0.00001748279,0.00006987182,0.0003302052,0.00446338,0.0001026233,0.001035993,0.00003190498,0.00006901677,0.0003952597,0.001495332,0.9919763,0.0000127122],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002496012,0.9954334,0.0002529037,0.0007590987,0.0003228546,0.00001818505,0.00007451753,0.00001383995,0.002875517],"genre_scores_gemma":[0.001226589,0.9969838,0.0002645845,0.0003783248,0.000202288,0.00001377497,0.00007765901,0.000002083955,0.0008508587],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.008273547,"threshold_uncertainty_score":0.02767777,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1969081293","doi":"10.1517/13543776.2014.898753","title":"LEDGINs, non-catalytic site inhibitors of HIV-1 integrase: a patent review (2006 – 2014)","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Integrase; Allosteric regulation; Integrase inhibitor; Human immunodeficiency virus (HIV); Biology; Computational biology; Pharmacology; Virology; Enzyme; Antiretroviral therapy; Biochemistry; Viral load","authors":[{"name":"Jonas Demeulemeester","is_ca":false},{"name":"Patrick Chaltin","is_ca":false},{"name":"Arnaud Marchand","is_ca":false},{"name":"Marc De Maeyer","is_ca":false},{"name":"Zeger Debyser","is_ca":false},{"name":"Frauke Christ","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07985944761990504,"gpt":0.3579603441142575,"spread":0.2781008964943525,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003653791,0.000725437,0.0009685858,0.002166311,0.0002211198,0.0008018047,0.00065667,0.0008466286,0.009771365],"category_scores_gemma":[0.0005320279,0.0002247733,0.0006297823,0.002513838,0.0002644359,0.000932023,0.0003772004,0.001205968,0.003681126],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005049613,"about_ca_system_score_gemma":0.001034052,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008212489,"about_ca_topic_score_gemma":0.001833693,"domain_scores_codex":[0.9998519,0.00001714536,0.00001566702,0.00002507219,0.00006963866,0.00002059206],"domain_scores_gemma":[0.9998116,0.00006819233,0.00004869514,0.000004173886,0.00004924814,0.00001804322],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008729694,0.00005418933,0.00007715163,0.01921755,0.00008358963,0.0002219084,0.00004391622,0.0002588682,0.002006118,0.002923476,0.04165119,0.9333747],"study_design_scores_gemma":[0.0000360806,0.0001277173,0.000566237,0.004224136,0.0001526663,0.0007739362,0.00003167088,0.00006071755,0.000594256,0.0008458018,0.9925724,0.00001450143],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002995385,0.9955213,0.0001651215,0.0004063962,0.0003111236,0.00002123646,0.00009047362,0.00001612154,0.003168695],"genre_scores_gemma":[0.001638577,0.9961255,0.0002055402,0.0002605564,0.0001482533,0.00001318534,0.0001072053,0.000002050983,0.00149917],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.009771365,"threshold_uncertainty_score":0.0326885,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2006746802","doi":"10.1517/13543776.2010.505604","title":"17β-Hydroxysteroid dehydrogenase inhibitors: a patent review","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":82,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Dehydrogenase; Hydroxysteroid dehydrogenase; Chemistry; Biochemistry; Enzyme; Pharmacology; Biology","authors":[{"name":"Donald Poirier","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07400655074951908,"gpt":0.3529148804783789,"spread":0.2789083297288599,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006941305,0.0005889365,0.0008844887,0.001317432,0.0002652728,0.001367031,0.0007357828,0.001463317,0.01341259],"category_scores_gemma":[0.001410228,0.0001817732,0.0007315302,0.001722672,0.0002935863,0.001564985,0.0004716091,0.001737212,0.005054986],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005656023,"about_ca_system_score_gemma":0.001576524,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005827989,"about_ca_topic_score_gemma":0.001097896,"domain_scores_codex":[0.9997223,0.00004063758,0.00002733748,0.00004368058,0.0001311237,0.00003495806],"domain_scores_gemma":[0.9994246,0.0002209008,0.0001159428,0.00001376174,0.0001732573,0.00005162771],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001008074,0.00007122658,0.0001166976,0.0123829,0.00007907066,0.0003827477,0.00005543783,0.0002304809,0.001502128,0.005135185,0.1369035,0.8430398],"study_design_scores_gemma":[0.00002197523,0.00007425351,0.000248951,0.002850811,0.0001050647,0.0005544499,0.00002645334,0.00005640178,0.000293119,0.001731753,0.9940276,0.000009173314],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005403394,0.981977,0.0006523814,0.005817413,0.002456425,0.00003857649,0.0002042053,0.00004720355,0.008266453],"genre_scores_gemma":[0.002454228,0.989683,0.0005177797,0.002190014,0.001142211,0.00003272151,0.0001985458,0.00000806159,0.003773466],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01341259,"threshold_uncertainty_score":0.0448696,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2500524559","doi":"10.1080/13543776.2016.1216545","title":"Therapeutic significance of quinolines: a patent review (2013-2015)","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Synthesis and Reactivity of Heterocycles","field":"Chemistry","cited_by":68,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Quinoline; Pharmacophore; Antimicrobial; Broad spectrum; Combinatorial chemistry; Chemistry; Pharmacology; Medicine; Computational biology; Biology; Bioinformatics; Organic chemistry","authors":[{"name":"S.M. Ali Hussaini","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1785058521527395,"gpt":0.3792114764262831,"spread":0.2007056242735437,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004276765,0.0006907584,0.000815973,0.00262702,0.0002870037,0.0009950873,0.0006344171,0.0007396166,0.01005551],"category_scores_gemma":[0.0006212196,0.000228608,0.0006252489,0.002378316,0.0002849784,0.001105924,0.0004958797,0.001189212,0.003260745],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006434078,"about_ca_system_score_gemma":0.00113758,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009026814,"about_ca_topic_score_gemma":0.002084689,"domain_scores_codex":[0.9998456,0.00001637504,0.00001716697,0.00002882791,0.00006650302,0.00002546011],"domain_scores_gemma":[0.9997881,0.0000639375,0.00005372076,0.000005788842,0.00006530958,0.0000230803],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008488065,0.0000709176,0.0001441899,0.01604841,0.00007114623,0.0004968888,0.00006806862,0.0003910107,0.003942413,0.00469307,0.02989722,0.9440918],"study_design_scores_gemma":[0.00002443893,0.0001346665,0.0008155743,0.003408039,0.0001380064,0.001390642,0.00004808605,0.0001013161,0.001242528,0.001201932,0.9914783,0.00001650186],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0008480558,0.9906584,0.0003852829,0.0007046736,0.0003716689,0.00003530057,0.0001576911,0.00002440745,0.006814457],"genre_scores_gemma":[0.0044353,0.9917024,0.0003908813,0.0003812773,0.0002010375,0.00002032441,0.0001592406,0.00000390421,0.002705661],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01005551,"threshold_uncertainty_score":0.03363901,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1769059961","doi":"10.1517/13543776.2015.1086749","title":"A STAT inhibitor patent review: progress since 2011","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dairy Farmers of Ontario; University of Toronto","funders":"","keywords":"STAT5; stat; SH2 domain; Computational biology; STAT3; Cancer research; Biology; Kinase; Phosphorylation; Genetics","authors":[{"name":"Ping‐Shan Lai","is_ca":true},{"name":"David A. Rosa","is_ca":true},{"name":"Rodolfo F. Gómez‐Biagi","is_ca":true},{"name":"Daniel P. Ball","is_ca":true},{"name":"Andrew E. Shouksmith","is_ca":true},{"name":"Patrick T. Gunning","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3069633868370701,"gpt":0.4409019624140757,"spread":0.1339385755770056,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000691614,0.0007014885,0.001065036,0.002202331,0.0002951616,0.00115611,0.0007917522,0.001011768,0.009269314],"category_scores_gemma":[0.00131996,0.0002151469,0.0007748138,0.002542673,0.0003763167,0.001423661,0.0005439257,0.001620497,0.003421645],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006648733,"about_ca_system_score_gemma":0.0016536,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007849965,"about_ca_topic_score_gemma":0.001879471,"domain_scores_codex":[0.9997217,0.0000368579,0.00004015167,0.00005152254,0.0001144375,0.000035348],"domain_scores_gemma":[0.9993799,0.0002588286,0.0001210354,0.00001199366,0.0001855558,0.00004262145],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009634613,0.0000470933,0.0001114254,0.022781,0.0000830257,0.0002340812,0.00004976122,0.000212781,0.00153698,0.002382881,0.06096811,0.9114965],"study_design_scores_gemma":[0.00002423189,0.00009732864,0.0004023947,0.004153929,0.0001766193,0.0008374633,0.00003969558,0.000054647,0.000603918,0.00100125,0.9925956,0.00001293079],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002740907,0.9954233,0.0001719555,0.00102561,0.0005595644,0.00001357046,0.0000878596,0.00001624559,0.002427837],"genre_scores_gemma":[0.001237662,0.9964143,0.0002021918,0.000634541,0.0003293931,0.000008962588,0.0001191217,0.000002575906,0.001051229],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.009269314,"threshold_uncertainty_score":0.03100896,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2590195415","doi":"10.1080/13543776.2017.1297796","title":"Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016 –<i>Part I</i>","year":2017,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Nerve injury and regeneration","field":"Neuroscience","cited_by":50,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Trk receptor; Tropomyosin receptor kinase A; Kinase; Context (archaeology); Biology; Receptor; Neurotrophin; Cell biology; Biochemistry","authors":[{"name":"Justin J. Bailey","is_ca":true},{"name":"Ralf Schirrmacher","is_ca":true},{"name":"Kristen B. Farrell","is_ca":true},{"name":"Vadim Bernard‐Gauthier","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.4089902481238907,"gpt":0.4358830275645397,"spread":0.026892779440649,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003942893,0.0007720017,0.0009613209,0.00235517,0.0002637143,0.001049571,0.0007601191,0.0008153761,0.0144481],"category_scores_gemma":[0.0007319257,0.0002288053,0.0007798173,0.002217517,0.0002541726,0.001384683,0.0005342899,0.001407932,0.005166077],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006728214,"about_ca_system_score_gemma":0.001374846,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009862685,"about_ca_topic_score_gemma":0.002611667,"domain_scores_codex":[0.9998118,0.0000209435,0.00002626045,0.00003257524,0.00008012762,0.00002836909],"domain_scores_gemma":[0.9997689,0.0000708192,0.00005979966,0.00000582556,0.00007356585,0.00002105995],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001011609,0.00006422283,0.00009048074,0.02267423,0.00008065679,0.0003039798,0.00006314176,0.0002668983,0.003399323,0.003694152,0.0996569,0.8696049],"study_design_scores_gemma":[0.00001897121,0.00008213351,0.0003813223,0.002876286,0.0001090134,0.0007351332,0.00002458402,0.00005472388,0.0004856002,0.0007286708,0.9944907,0.00001282278],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005308429,0.9885262,0.0003600376,0.001261557,0.001032517,0.00004587543,0.0003720131,0.00004237054,0.007828536],"genre_scores_gemma":[0.001907614,0.9928008,0.0003780324,0.0007519617,0.0003931669,0.00002635938,0.0003796253,0.000005939395,0.003356381],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0144481,"threshold_uncertainty_score":0.0483337,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4231919180","doi":"10.1080/13543776.2017.1297797","title":"Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016 – <i>Part II</i>","year":2017,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Signaling Pathways in Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Trk receptor; Tropomyosin receptor kinase A; Drug development; Medicine; Pharmacology; Cancer research; Internal medicine; Drug; Receptor; Neurotrophin","authors":[{"name":"Justin J. Bailey","is_ca":true},{"name":"Ralf Schirrmacher","is_ca":true},{"name":"Kristen B. Farrell","is_ca":true},{"name":"Vadim Bernard‐Gauthier","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2270398082199384,"gpt":0.4052185314502031,"spread":0.1781787232302647,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003842787,0.0007471179,0.0008947469,0.002060885,0.0002473611,0.001024964,0.0007306496,0.0007965682,0.01434572],"category_scores_gemma":[0.0006686667,0.0002309344,0.0007345116,0.00195957,0.000246998,0.001351871,0.0005153315,0.001454822,0.005380455],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006828929,"about_ca_system_score_gemma":0.001248154,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008883042,"about_ca_topic_score_gemma":0.002408788,"domain_scores_codex":[0.9998232,0.00001975726,0.00002291567,0.00003040089,0.00007586525,0.00002789519],"domain_scores_gemma":[0.9997967,0.00005950618,0.00005172121,0.000005283257,0.00006627412,0.00002060122],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001003729,0.00006483311,0.00008317237,0.01791119,0.000073348,0.0003053169,0.00005704014,0.0002850315,0.003778342,0.003914504,0.1101916,0.8632352],"study_design_scores_gemma":[0.00001893903,0.00007837294,0.0003180592,0.002058897,0.00008536935,0.0007046966,0.00002028841,0.00005500522,0.0004934957,0.0006926061,0.9954625,0.00001171469],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006138773,0.9865173,0.0004471196,0.001595421,0.001298721,0.00005051338,0.0003917433,0.00004912041,0.009036187],"genre_scores_gemma":[0.002192351,0.9911724,0.0004391225,0.0009423847,0.0004672077,0.00002884134,0.0004185382,0.000007060505,0.004332162],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01434572,"threshold_uncertainty_score":0.04799116,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2020159664","doi":"10.1517/13543776.2010.533171","title":"Diabetes area participation analysis: a review of companies and targets described in the 2008 – 2010 patent literature","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Natural Antidiabetic Agents Studies","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"University of Calgary; F. Hoffmann-La Roche","keywords":"Medicine; Diabetes mellitus; Type 2 diabetes; Macrovascular disease; Insulin resistance; Glycemic; Insulin; Disease; Diabetic retinopathy; Nephropathy; Retinopathy; Obesity; Internal medicine; Endocrinology; Intensive care medicine","authors":[{"name":"Philip A. Carpino","is_ca":false},{"name":"Bryan Goodwin","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.161926584440197,"gpt":0.3811564945442865,"spread":0.2192299101040895,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["bibliometrics"],"consensus_categories":[],"category_scores_codex":[0.001109023,0.0006884676,0.0009973305,0.008859657,0.0003103269,0.00151792,0.0007281955,0.0008252941,0.01851132],"category_scores_gemma":[0.003334792,0.0001873394,0.001299392,0.01380328,0.0002270263,0.001306234,0.0006345511,0.0006742332,0.003925547],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001167236,"about_ca_system_score_gemma":0.002367615,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001794562,"about_ca_topic_score_gemma":0.003328002,"domain_scores_codex":[0.9989287,0.0001498916,0.0001778646,0.000119618,0.000524672,0.00009916814],"domain_scores_gemma":[0.9973931,0.0009424364,0.0008458304,0.00003530574,0.0006600694,0.000123178],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002118415,0.0001039771,0.0009660734,0.03244585,0.0001862309,0.0002670409,0.00008022618,0.0001301834,0.000958837,0.001368876,0.1033228,0.8599581],"study_design_scores_gemma":[0.00008230629,0.0002675484,0.009446633,0.02208948,0.0008861782,0.001143856,0.0002052506,0.0001024724,0.0008266394,0.000470107,0.9644521,0.0000274038],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001737966,0.9819092,0.0002393196,0.001890608,0.0004975629,0.00009883294,0.001820009,0.00004092167,0.0117657],"genre_scores_gemma":[0.008979228,0.9829262,0.0004730092,0.001345977,0.000527776,0.0001049985,0.001551932,0.00001403303,0.004076838],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9911404,"threshold_uncertainty_score":0.06192654,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1989556851","doi":"10.1517/13543770903059125","title":"The search for new COX-2 inhibitors: a review of 2002 – 2008 patents","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Fundação de Amparo à Pesquisa do Estado de Minas Gerais; Merck Canada; Conselho Nacional de Desenvolvimento Científico e Tecnológico","keywords":"Naproxen; Valdecoxib; Celecoxib; Medicine; Ibuprofen; Pharmacology; Inflammation; Cyclooxygenase; Nabumetone; Aspirin; Etoricoxib; Nonsteroidal; Chemistry; Enzyme; Rofecoxib; Internal medicine; Biochemistry","authors":[{"name":"Teodorico C. Ramalho","is_ca":false},{"name":"Marcus VJ Rocha","is_ca":false},{"name":"Elaine FF da Cunha","is_ca":false},{"name":"Matheus P. Freitas","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1324520550520304,"gpt":0.4087917491154659,"spread":0.2763396940634354,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005654444,0.000990247,0.001415107,0.004051274,0.0002784392,0.0008630234,0.0008635869,0.0008962286,0.007669982],"category_scores_gemma":[0.00086089,0.0003176877,0.0006458634,0.00461293,0.0002676747,0.001445955,0.0004371291,0.0008794495,0.002801797],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008698654,"about_ca_system_score_gemma":0.001254633,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001015904,"about_ca_topic_score_gemma":0.002930473,"domain_scores_codex":[0.9997639,0.00003064461,0.00003551642,0.00003611589,0.0001127175,0.00002112703],"domain_scores_gemma":[0.9996498,0.0001086895,0.00009148942,0.000007459984,0.0001092083,0.00003336612],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001175676,0.0000835235,0.0001560655,0.02335889,0.0001299099,0.0005179402,0.00006380517,0.0003363813,0.00211194,0.001568173,0.05024028,0.9213155],"study_design_scores_gemma":[0.00006849528,0.0001928993,0.001249094,0.006640683,0.0003119779,0.001731032,0.00007120697,0.0001215437,0.0006922183,0.0009618573,0.9879382,0.000020741],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003245483,0.9968808,0.000107099,0.0004118642,0.0002307347,0.00001366957,0.00004819615,0.000008069278,0.001975014],"genre_scores_gemma":[0.001033253,0.9971239,0.0002555464,0.00032391,0.0002315618,0.00001029257,0.00009153367,0.000001456836,0.0009285542],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007669982,"threshold_uncertainty_score":0.02565867,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2173701041","doi":"10.1517/13543776.2016.1115836","title":"Transglutaminase inhibitors: a patent review","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Blood properties and coagulation","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa","funders":"","keywords":"Tissue transglutaminase; Deamidation; Glutamine; Enzyme; Disease; GTP'; Cancer; Biochemistry; Pharmacology; Chemistry; Medicine; Biology; Cancer research; Amino acid; Internal medicine","authors":[{"name":"Jeffrey W. Keillor","is_ca":true},{"name":"Kim Yang-Ping Apperley","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3485761927403397,"gpt":0.4178338653797347,"spread":0.06925767263939497,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004704152,0.0006579204,0.001035997,0.001874338,0.000258575,0.0009920034,0.0007309748,0.00106428,0.01141726],"category_scores_gemma":[0.0008942913,0.0002045621,0.0007083643,0.001940046,0.0002586059,0.001115039,0.0004554253,0.001296779,0.003588118],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005046747,"about_ca_system_score_gemma":0.001148439,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007375916,"about_ca_topic_score_gemma":0.00144127,"domain_scores_codex":[0.9998098,0.0000256624,0.00002344991,0.00003105511,0.00008818443,0.0000218856],"domain_scores_gemma":[0.9997023,0.0001293199,0.00006156549,0.000006598895,0.00007786571,0.00002238733],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007875446,0.00005844379,0.00008890334,0.01990248,0.00009170269,0.0003339699,0.00004995922,0.0002263917,0.001348841,0.003698163,0.0619744,0.9121479],"study_design_scores_gemma":[0.00002694937,0.00008109835,0.0003397666,0.006190899,0.0001528729,0.0009519801,0.00003324555,0.00005435808,0.000321491,0.001399212,0.9904373,0.00001067043],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002502009,0.9950116,0.0001556448,0.0009237844,0.0003794683,0.0000166106,0.00008722836,0.00001381075,0.003161686],"genre_scores_gemma":[0.001345143,0.9965504,0.0001797316,0.0004727248,0.0002362102,0.00001236857,0.00009831869,0.000002023168,0.001103084],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01141726,"threshold_uncertainty_score":0.0381946,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1769626824","doi":"10.1517/13543776.12.4.513","title":"Recent progress in 5-HT<sub>6</sub>receptor antagonists for the treatment of CNS diseases","year":2002,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Neurotransmitter Receptor Influence on Behavior","field":"Neuroscience","cited_by":35,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Discovery Centre","funders":"","keywords":"Serotonergic; Medicine; Mechanism (biology); 5-HT6 receptor; Schizophrenia (object-oriented programming); Neuroscience; Intensive care medicine; Pharmacology; Psychiatry; 5-HT receptor; Psychology; Receptor; Serotonin; Internal medicine; Epistemology; Philosophy","authors":[{"name":"Abdelmalik Slassi","is_ca":true},{"name":"Methvin Isaac","is_ca":true},{"name":"Anne O’Brien","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1194992108277012,"gpt":0.3431025908647595,"spread":0.2236033800370584,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001964008,0.0005108443,0.0008485083,0.001471364,0.0003844454,0.001358411,0.0006004717,0.001386172,0.007859949],"category_scores_gemma":[0.001422284,0.0002319322,0.0004692765,0.001562229,0.000482495,0.001955251,0.0004678094,0.001094309,0.002212049],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005503844,"about_ca_system_score_gemma":0.0009637497,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004938429,"about_ca_topic_score_gemma":0.001490883,"domain_scores_codex":[0.9996401,0.0001045347,0.00006148215,0.00004644494,0.0000981523,0.00004918633],"domain_scores_gemma":[0.9988939,0.0006489356,0.0001370748,0.00002961839,0.0002306761,0.00005980684],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006865528,0.0002813612,0.0004378151,0.0100058,0.0000914334,0.001075419,0.0002806705,0.0006445213,0.01736365,0.009760004,0.02163667,0.9377361],"study_design_scores_gemma":[0.0001460392,0.001455899,0.003245695,0.001842016,0.0004488103,0.003874529,0.0003492063,0.0005069837,0.0101244,0.007589874,0.9703771,0.00003940082],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003857708,0.9760551,0.002046866,0.00672043,0.0008742256,0.0000183774,0.00004063792,0.00004851094,0.01033816],"genre_scores_gemma":[0.01483024,0.9749151,0.002399354,0.001908765,0.002419214,0.00002332266,0.00008306735,0.00001035723,0.00341057],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007859949,"threshold_uncertainty_score":0.02629411,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2010505546","doi":"10.1517/13543776.2011.593510","title":"Cyclooxygenase-2 inhibitors: a literature and patent review (2009 – 2010)","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta Hospital; University of Alberta","funders":"","keywords":"Cyclooxygenase; Chemistry; Pharmacology; Medicine; Biochemistry; Enzyme","authors":[{"name":"Baker Jawabrah Al‐Hourani","is_ca":true},{"name":"Sai Kiran Sharma","is_ca":true},{"name":"Mavanur R. Suresh","is_ca":true},{"name":"Frank Wuest","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1377688192194239,"gpt":0.3557674840241276,"spread":0.2179986648047037,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004339543,0.0007108232,0.001098362,0.003057272,0.0002282778,0.0008148091,0.0007895232,0.0009433333,0.0170427],"category_scores_gemma":[0.0009311239,0.0001970593,0.0008274103,0.003548236,0.0002317297,0.001096635,0.0004286873,0.0009756883,0.006017359],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005592377,"about_ca_system_score_gemma":0.001505055,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009703264,"about_ca_topic_score_gemma":0.002488364,"domain_scores_codex":[0.999765,0.00002885634,0.00003158224,0.00003835428,0.0001048478,0.00003134983],"domain_scores_gemma":[0.9995332,0.00009334138,0.0001293254,0.000009831018,0.000197258,0.00003718214],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001498934,0.00006661383,0.0001983006,0.02152845,0.0001196332,0.000383886,0.00004015672,0.0001966539,0.001823767,0.0009920535,0.1048566,0.8696439],"study_design_scores_gemma":[0.00007395479,0.0002038397,0.002552178,0.01110686,0.0004999972,0.00226713,0.00005669326,0.0001176206,0.0009082032,0.0008055383,0.9813823,0.00002575113],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000670063,0.991017,0.0002247568,0.001799016,0.0008607242,0.00003337698,0.0004216694,0.00002521129,0.004948213],"genre_scores_gemma":[0.003136818,0.9921277,0.0002817755,0.001094474,0.0007099852,0.00001995295,0.0005380578,0.000004112101,0.002087056],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0170427,"threshold_uncertainty_score":0.05701351,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3081954160","doi":"10.1080/13543776.2020.1817390","title":"Inhibitors of type II transmembrane serine proteases in the treatment of diseases of the respiratory tract – A review of patent literature","year":2020,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Liver physiology and pathology","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Sherbrooke","funders":"Canadian Institutes of Health Research","keywords":"Proteases; TMPRSS2; Respiratory tract; Transmembrane protein; Serine; Biology; Medicine; Pharmacology; Respiratory system; Immunology; Enzyme; Receptor; Coronavirus disease 2019 (COVID-19); Biochemistry; Pathology; Disease; Internal medicine; Infectious disease (medical specialty)","authors":[{"name":"Alexandre Murza","is_ca":true},{"name":"Sébastien P. Dion","is_ca":true},{"name":"Pierre‐Luc Boudreault","is_ca":true},{"name":"Antoine Désilets","is_ca":true},{"name":"Richard Leduc","is_ca":true},{"name":"Éric Marsault","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1508476443493234,"gpt":0.3814635435339384,"spread":0.230615899184615,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005410554,0.0005401789,0.0008478651,0.001384783,0.0001721461,0.0008489321,0.0006246361,0.0008177661,0.008748208],"category_scores_gemma":[0.0006255413,0.000143061,0.0006399076,0.001174051,0.0002254282,0.000974449,0.0003565061,0.001118997,0.00296897],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003859392,"about_ca_system_score_gemma":0.000720756,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004348833,"about_ca_topic_score_gemma":0.0009764173,"domain_scores_codex":[0.9998203,0.00002679141,0.00001764481,0.00003072022,0.0000758696,0.00002862875],"domain_scores_gemma":[0.9997229,0.0001093021,0.00006135218,0.000005296048,0.00008020076,0.00002087837],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001691245,0.00008108778,0.000130862,0.0169618,0.0001270371,0.0004077694,0.00005810888,0.0004418065,0.0035213,0.003767533,0.06239723,0.9119363],"study_design_scores_gemma":[0.00007166671,0.0002491087,0.0006400257,0.005458961,0.000243729,0.001023591,0.00004893635,0.0001960006,0.0008822946,0.002385572,0.9887793,0.00002079973],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0007476216,0.9916717,0.0005302285,0.001883027,0.0007876008,0.00003068655,0.0001680112,0.00003038605,0.0041506],"genre_scores_gemma":[0.002946752,0.9936236,0.0003231961,0.0008440247,0.0005300242,0.00002549092,0.0001695891,0.000004058623,0.001533391],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.008748208,"threshold_uncertainty_score":0.02926564,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2466927139","doi":"10.1080/13543776.2016.1206080","title":"Proprotein convertase subtilisin / kexin 9 (PCSK9) inhibitors and the future of dyslipidemia therapy: an updated patent review (2011-2015)","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Fondation Leducq","keywords":"PCSK9; Alirocumab; Evolocumab; Kexin; Proprotein convertase; Dyslipidemia; Medicine; Pharmacology; Monoclonal antibody; Cholesterol; LDL receptor; Antibody; Internal medicine; Immunology; Lipoprotein; Disease","authors":[{"name":"Sandy Elbitar","is_ca":false},{"name":"Petra El Khoury","is_ca":false},{"name":"Youmna Ghaleb","is_ca":false},{"name":"Jean‐Pierre Rabès","is_ca":false},{"name":"Mathilde Varret","is_ca":false},{"name":"Nabil G. Seidah","is_ca":true},{"name":"Cathérine Boileau","is_ca":false},{"name":"Marianne Abifadel","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08188793832644997,"gpt":0.3603073481168442,"spread":0.2784194097903943,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000623994,0.0005942097,0.0009380673,0.002460952,0.0002679438,0.001168902,0.0005340066,0.001006133,0.007181922],"category_scores_gemma":[0.001005274,0.0002025326,0.0007471264,0.00245108,0.0002710866,0.001507212,0.000560586,0.001356351,0.002102587],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006509505,"about_ca_system_score_gemma":0.001482034,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008657954,"about_ca_topic_score_gemma":0.001876344,"domain_scores_codex":[0.9997504,0.00003493222,0.00003704969,0.00003825794,0.0001105155,0.00002883309],"domain_scores_gemma":[0.9996036,0.0001648812,0.00008246543,0.000007168544,0.0001168742,0.00002506611],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008085599,0.00005236011,0.0001348873,0.01943889,0.00008841042,0.0002554381,0.00007379996,0.0002254743,0.001328994,0.003938598,0.0492129,0.9251693],"study_design_scores_gemma":[0.00002973237,0.0001123458,0.0007764707,0.008141415,0.0002233454,0.001225164,0.00007086651,0.00009873017,0.0003737918,0.001810757,0.9871174,0.00002007771],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002034965,0.9971439,0.00009803886,0.0008510457,0.0003471498,0.000006093775,0.00003790402,0.000007057957,0.001305267],"genre_scores_gemma":[0.0008343521,0.9976727,0.0001324765,0.0003775658,0.000268443,0.000005035476,0.00004853345,0.000001249051,0.0006596654],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007181922,"threshold_uncertainty_score":0.02402592,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2084903264","doi":"10.1517/13543776.17.4.371","title":"Metabotropic glutamate receptor 5 modulators and their potential therapeutic applications","year":2007,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto Public Health","funders":"AstraZeneca","keywords":"Metabotropic glutamate receptor; Metabotropic glutamate receptor 5; Neuroscience; Metabotropic receptor; Metabotropic glutamate receptor 2; Glutamate receptor; Receptor; Class C GPCR; Metabotropic glutamate receptor 1; Metabotropic glutamate receptor 7; Pharmacology; Biology; Biochemistry","authors":[{"name":"Peter Bach","is_ca":false},{"name":"Methvin Isaac","is_ca":true},{"name":"Abdelmalik Slassi","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08032992125195253,"gpt":0.3618215717416292,"spread":0.2814916504896767,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004347198,0.0004949805,0.0006161994,0.0008759655,0.0001802709,0.0007142601,0.0005483721,0.0009950295,0.008578535],"category_scores_gemma":[0.0004177263,0.0001284335,0.0005636936,0.0005576406,0.0002343341,0.000566533,0.0004267343,0.001496271,0.002499495],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004271039,"about_ca_system_score_gemma":0.0003516757,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003656334,"about_ca_topic_score_gemma":0.001220569,"domain_scores_codex":[0.9998587,0.00002845784,0.00001291027,0.00002239011,0.00004945039,0.00002809865],"domain_scores_gemma":[0.9999046,0.00002112682,0.000026472,0.000003508152,0.00002884738,0.00001546344],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005483415,0.0003151504,0.0003467948,0.005495959,0.0001038388,0.000812438,0.0001148043,0.0006126025,0.02098024,0.01639379,0.03507631,0.9191997],"study_design_scores_gemma":[0.0001737076,0.001210615,0.001334905,0.001520509,0.0001223343,0.001717235,0.00006625557,0.0004085261,0.00499532,0.005364552,0.9830555,0.00003063122],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004042969,0.9767402,0.001413581,0.002963979,0.0008518746,0.00004578093,0.000219602,0.00006899016,0.01365305],"genre_scores_gemma":[0.03666609,0.945752,0.002608974,0.003271958,0.001173726,0.00009522153,0.0004778485,0.00001173523,0.009942451],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.008578535,"threshold_uncertainty_score":0.02869809,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2156817850","doi":"10.1517/13543776.16.7.977","title":"TRPV1 antagonists: a survey of the patent literature","year":2006,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Ion Channels and Receptors","field":"Neuroscience","cited_by":22,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Purdue Pharma (Canada)","funders":"","keywords":"TRPV1; Pharmacology; Medicine; Clinical trial; Computational biology; Business; Biology; Receptor; Internal medicine; Transient receptor potential channel","authors":[{"name":"Donald J. Kyle","is_ca":true},{"name":"Laykea Tafesse","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1222570584195841,"gpt":0.3083448457455742,"spread":0.1860877873259901,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001571242,0.0007550649,0.001339923,0.00858288,0.0004308704,0.001429969,0.0009702741,0.001161781,0.009219827],"category_scores_gemma":[0.003210639,0.0002571758,0.00079513,0.007865391,0.0004053784,0.002575795,0.0004946935,0.0008217377,0.002579619],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009191451,"about_ca_system_score_gemma":0.00133247,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006841915,"about_ca_topic_score_gemma":0.001202927,"domain_scores_codex":[0.9993161,0.00008083621,0.0001101966,0.0001042785,0.0003307417,0.00005792727],"domain_scores_gemma":[0.9978555,0.001063618,0.0004957896,0.00004311269,0.0004313504,0.0001106428],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003202759,0.0001370339,0.0009010887,0.01230155,0.0001330582,0.001445349,0.0001265053,0.0004239981,0.00415455,0.002401452,0.02392267,0.9537326],"study_design_scores_gemma":[0.0001386281,0.000977273,0.009312505,0.008930205,0.0007463665,0.008914697,0.0002895571,0.0004443449,0.00372707,0.004214838,0.9622537,0.00005101248],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003318348,0.9898912,0.0004116718,0.00132113,0.0001506175,0.00002157798,0.0002016164,0.00002408256,0.004659715],"genre_scores_gemma":[0.007405936,0.9900401,0.0005027557,0.0005594801,0.0002734628,0.00001908524,0.0002679404,0.000005925376,0.0009251909],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.009219827,"threshold_uncertainty_score":0.03084338,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2018494913","doi":"10.1517/13543776.2014.851669","title":"An overview of patented small molecule stearoyl coenzyme-A desaturase inhibitors (2009 – 2013)","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Aboriginal Affairs Northern Dev Canada","funders":"Glenmark Pharmaceuticals; Pfizer","keywords":"Adverse effect; Pharmacology; Medicine; Small molecule; Fatty liver; Bioinformatics; Biology; Cancer research; Biochemistry; Internal medicine","authors":[{"name":"David Powell","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.27537770642034,"gpt":0.4409548434803954,"spread":0.1655771370600554,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005079265,0.001004126,0.001198816,0.003532225,0.0003099233,0.0008779583,0.0008406542,0.001061845,0.009146526],"category_scores_gemma":[0.0006982171,0.0003492353,0.0007623215,0.002790288,0.0003076744,0.001362375,0.0005732108,0.001594052,0.004519394],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006820302,"about_ca_system_score_gemma":0.000920732,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001052911,"about_ca_topic_score_gemma":0.002250828,"domain_scores_codex":[0.9997991,0.00002476815,0.0000333392,0.00004124564,0.00008032644,0.00002117225],"domain_scores_gemma":[0.9997179,0.0001060188,0.00005902774,0.000006666084,0.00008488305,0.00002559937],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007564291,0.0001039212,0.0001020196,0.0194471,0.00006688273,0.0002561338,0.0000502332,0.0002498216,0.00275081,0.002380462,0.03100784,0.943509],"study_design_scores_gemma":[0.00002957212,0.0001739266,0.000694957,0.004604161,0.0001266881,0.001233989,0.00004132852,0.0001010028,0.0009251841,0.0008274917,0.9912232,0.00001853374],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003130319,0.9946025,0.0002890823,0.0004156399,0.0003170652,0.00002988671,0.0001042171,0.0000221116,0.003906488],"genre_scores_gemma":[0.001179034,0.9960629,0.0003835949,0.0003118521,0.0001474688,0.00002297975,0.0001217254,0.000003009375,0.001767274],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.009146526,"threshold_uncertainty_score":0.0305981,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2020008986","doi":"10.1517/13543776.12.8.1215","title":"Gangliosides: therapeutic agents or therapeutic targets?","year":2002,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"","keywords":"Neurodegeneration; Drug; Computational biology; Glycolipid; Drug discovery; Biology; Neuroscience; Pharmacology; Medicine; Immunology; Bioinformatics; Disease","authors":[{"name":"H. Uri Saragovi","is_ca":true},{"name":"Martin Gagnon","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.110599248225029,"gpt":0.3483887617806951,"spread":0.2377895135556661,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008950769,0.0006702604,0.001296207,0.000693422,0.0003560722,0.001688431,0.0006507864,0.002149006,0.006321996],"category_scores_gemma":[0.0005207451,0.0001602629,0.0002230835,0.0006832184,0.001564299,0.003275491,0.00072297,0.001711549,0.003124351],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001072827,"about_ca_system_score_gemma":0.0008516776,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003898634,"about_ca_topic_score_gemma":0.0006918916,"domain_scores_codex":[0.9996833,0.000097991,0.0000254016,0.00004537066,0.00009619021,0.00005184384],"domain_scores_gemma":[0.9998449,0.00004581719,0.000029025,0.00001417991,0.00003754327,0.00002842725],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006559875,0.0001939613,0.0005760728,0.004549636,0.00006734573,0.001388089,0.0002435206,0.0004058242,0.03575437,0.138547,0.05638076,0.7612373],"study_design_scores_gemma":[0.0001461351,0.0003779678,0.0003999306,0.0008421493,0.00007320415,0.002835706,0.0003478829,0.0002253284,0.01102465,0.05156966,0.9321269,0.00003047784],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003993617,0.9456298,0.00250947,0.02966613,0.002351374,0.00004509051,0.00009155502,0.00005584724,0.01565722],"genre_scores_gemma":[0.04053032,0.9288251,0.002973226,0.009201131,0.003668854,0.0001047358,0.0001283818,0.00002287824,0.01454532],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006321996,"threshold_uncertainty_score":0.02114916,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2137798595","doi":"10.1517/13543771003702432","title":"Novel substituted heteroaromatic compounds as inhibitors of stearoyl-CoA desaturase","year":2010,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Steatosis; Pharmacology; Medicine; Disease; Metabolic syndrome; Diabetes mellitus; Chemistry; Bioinformatics; Biochemistry; Biology; Internal medicine; Endocrinology","authors":[{"name":"Paweł Dobrzyń","is_ca":false},{"name":"Agnieszka Dobrzyń","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0652826197250013,"gpt":0.3566787178923051,"spread":0.2913960981673038,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002457755,0.0002767766,0.0003600657,0.0004109596,0.0002023527,0.000328181,0.0004577881,0.0005704736,0.007317207],"category_scores_gemma":[0.0001779542,0.0000986606,0.0002202459,0.0003497829,0.0002266826,0.0005485049,0.0002268681,0.0005244441,0.001268504],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002703113,"about_ca_system_score_gemma":0.0002024286,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003011221,"about_ca_topic_score_gemma":0.0008819187,"domain_scores_codex":[0.9999138,0.00002088704,0.000004101354,0.00001397183,0.00002578521,0.00002154447],"domain_scores_gemma":[0.9999477,0.00001435446,0.00001379862,0.000003350278,0.00001125043,0.000009613746],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001571489,0.0008782843,0.0004882856,0.001545542,0.00006680226,0.002731794,0.0003727164,0.002031572,0.5722584,0.0274894,0.01238874,0.3781771],"study_design_scores_gemma":[0.00174556,0.009369711,0.004747877,0.0007809496,0.0002710127,0.005934065,0.0003073725,0.004257991,0.4425818,0.008386284,0.521509,0.0001083199],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.4524793,0.3585683,0.02415767,0.009220587,0.002100259,0.0008103637,0.0009626198,0.0002917056,0.1514092],"genre_scores_gemma":[0.77053,0.1731057,0.01141372,0.002464051,0.0007424976,0.0002054789,0.0005145289,0.0000325566,0.0409915],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007317207,"threshold_uncertainty_score":0.0244785,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2031439958","doi":"10.1517/13543776.11.4.625","title":"Novel serotonergic and non-serotonergic migraine headache therapies","year":2001,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"IDELIX Software (Canada)","funders":"","keywords":"Sumatriptan; Migraine; Rizatriptan; Zolmitriptan; Triptans; Medicine; Serotonergic; Pharmacology; Methysergide; Intensive care medicine; Neuroscience; Serotonin; Psychology; Agonist; Anesthesia; Internal medicine; Receptor","authors":[{"name":"Abdelmalik Slassi","is_ca":true},{"name":"Methvin Isaac","is_ca":true},{"name":"Jalaj Arora","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0809376976532069,"gpt":0.3430766452850072,"spread":0.2621389476318003,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002699914,0.0004494952,0.0005414929,0.0008813033,0.0002301095,0.0006034249,0.0004338614,0.0005418212,0.008317623],"category_scores_gemma":[0.0001781702,0.0001032518,0.0003943682,0.0003939429,0.0002144013,0.0006138038,0.0003310535,0.0006268895,0.001712249],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004097774,"about_ca_system_score_gemma":0.0002344336,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002298166,"about_ca_topic_score_gemma":0.0007972372,"domain_scores_codex":[0.9998821,0.0000138039,0.000008480738,0.00002077752,0.0000500539,0.00002480514],"domain_scores_gemma":[0.9999486,0.00001172613,0.00001248102,0.00000272004,0.00001387012,0.00001064488],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005803486,0.0005562818,0.0004286086,0.00420569,0.00007591351,0.001449044,0.0001398297,0.0006351068,0.09345236,0.01459656,0.01157457,0.8723057],"study_design_scores_gemma":[0.0006375419,0.005699029,0.008889639,0.001595818,0.0003232523,0.009507434,0.0001514657,0.001599119,0.06089048,0.008708934,0.9019316,0.00006569223],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.04657156,0.8949942,0.006032902,0.002797386,0.00147247,0.000221101,0.0006568045,0.0001626536,0.0470909],"genre_scores_gemma":[0.1634066,0.7861785,0.008588162,0.00269415,0.00255165,0.0002572968,0.0009456714,0.00002025124,0.03535777],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.008317623,"threshold_uncertainty_score":0.02782524,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1993341051","doi":"10.1517/13543776.12.12.1795","title":"Developments in mitogen-induced extracellular kinase 1 inhibitors and their use in the treatment of disease","year":2002,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital; University of Toronto","funders":"","keywords":"MAPK/ERK pathway; Kinase; Signal transduction; Cancer research; Extracellular; Protein kinase A; Mitogen-activated protein kinase; Immune system; ASK1; Biology; Cell biology; Medicine; Immunology; Mitogen-activated protein kinase kinase","authors":[{"name":"Joan C. Krepinsky","is_ca":true},{"name":"Dongcheng Wu","is_ca":true},{"name":"Alistair J. Ingram","is_ca":true},{"name":"James W. Scholey","is_ca":true},{"name":"Damu Tang","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08536307861861339,"gpt":0.2744875942477289,"spread":0.1891245156291156,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001194183,0.0006175819,0.0008323006,0.0009406274,0.0002586391,0.000806969,0.0006029136,0.001250791,0.003557009],"category_scores_gemma":[0.0005095804,0.0001936695,0.0004437691,0.0006286956,0.0005746405,0.0009399636,0.0003903375,0.001968247,0.001733725],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005101674,"about_ca_system_score_gemma":0.0004758575,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003786875,"about_ca_topic_score_gemma":0.0009935867,"domain_scores_codex":[0.9997388,0.00008220606,0.00002019752,0.00003573364,0.00008392109,0.0000392901],"domain_scores_gemma":[0.9997248,0.000139045,0.00004036819,0.00001406225,0.00005031334,0.0000313827],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008208301,0.0006001319,0.000485331,0.002344545,0.00008173285,0.001245766,0.0001395334,0.0008545725,0.05428091,0.01696722,0.01429571,0.9078838],"study_design_scores_gemma":[0.0007610078,0.002713379,0.002632232,0.0004896488,0.0001466248,0.005042769,0.00007140132,0.0008878004,0.03043495,0.008049482,0.9487237,0.00004713734],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01430022,0.9433109,0.007727202,0.008023686,0.0014237,0.0001046621,0.00009344928,0.000103041,0.02491315],"genre_scores_gemma":[0.08469233,0.8829606,0.0110151,0.004334831,0.003059758,0.0001963405,0.0002128896,0.00003188571,0.01349635],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003557009,"threshold_uncertainty_score":0.01189935,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4386945206","doi":"10.1080/13543776.2023.2262136","title":"Type I inhibitors of tropomyosin receptor kinase (Trk): a 2020–2022 patent update","year":2023,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"TRIUMF; University of British Columbia; University of Alberta","funders":"","keywords":"Trk receptor; Medicine; Precision medicine; Pharmacology; Bioinformatics; Cancer research; Computational biology; Biology; Receptor; Internal medicine; Neurotrophin; Pathology","authors":[{"name":"Carolin Jaworski","is_ca":true},{"name":"Petar Iliev","is_ca":true},{"name":"Carmen Wängler","is_ca":false},{"name":"Björn Wängler","is_ca":false},{"name":"Brent D. G. Page","is_ca":true},{"name":"Ralf Schirrmacher","is_ca":true},{"name":"Justin J. Bailey","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1103937892736046,"gpt":0.3584458892396905,"spread":0.2480520999660859,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063615,0.0007681282,0.0008214962,0.002226264,0.0002321483,0.001185876,0.0007996141,0.001178011,0.01927953],"category_scores_gemma":[0.0009696619,0.0001888788,0.0009245661,0.002103102,0.0002469648,0.001332467,0.0005223958,0.001542787,0.005962405],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007864243,"about_ca_system_score_gemma":0.001367206,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001045403,"about_ca_topic_score_gemma":0.002417961,"domain_scores_codex":[0.999765,0.00003210016,0.00002238451,0.00002837877,0.0001126819,0.00003947219],"domain_scores_gemma":[0.9996408,0.000123768,0.00007165685,0.000007797941,0.0001180266,0.00003801401],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001046767,0.00005895813,0.0000868586,0.01075042,0.00006032508,0.0002972566,0.0000353184,0.0002576337,0.001812406,0.003612386,0.1327875,0.8501363],"study_design_scores_gemma":[0.00003005964,0.00007166399,0.0002928907,0.002422625,0.00008287181,0.0005264697,0.00001413942,0.00005673074,0.000244209,0.0007993088,0.9954516,0.000007425489],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0007086503,0.97809,0.0004653363,0.003003828,0.00201637,0.00005547027,0.0004323235,0.0000653207,0.01516256],"genre_scores_gemma":[0.002731744,0.9869006,0.000452769,0.001964651,0.0008878051,0.00003709484,0.0004929149,0.000009665645,0.006522722],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01927953,"threshold_uncertainty_score":0.06449646,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1967410304","doi":"10.1517/13543776.2015.1010512","title":"Phosphorus-containing nanoparticles: biomedical patents review","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Nanotechnology; Phosphorus; Nanoparticle; Chemistry; Business; Materials science; Organic chemistry","authors":[{"name":"Dzmitry Shcharbin","is_ca":false},{"name":"Natallia Shcharbina","is_ca":false},{"name":"Antos Shakhbazau","is_ca":true},{"name":"Serge Mignani","is_ca":false},{"name":"Jean‐Pierre Majoral","is_ca":false},{"name":"Maria Bryszewska","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1421158192122157,"gpt":0.379793716350022,"spread":0.2376778971378063,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004117641,0.0009049299,0.0009800022,0.00272544,0.0003114298,0.0009994883,0.0006208387,0.001073404,0.008651671],"category_scores_gemma":[0.0006055892,0.0002547058,0.0004989138,0.002722952,0.0003140979,0.001256131,0.0005393254,0.001165315,0.004072949],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005685586,"about_ca_system_score_gemma":0.001137552,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009945513,"about_ca_topic_score_gemma":0.001500753,"domain_scores_codex":[0.9998232,0.00002114504,0.00002134751,0.00003272694,0.00008055607,0.00002111902],"domain_scores_gemma":[0.9997522,0.00009679233,0.00004890614,0.000006904337,0.0000723967,0.00002285083],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004412802,0.00005054181,0.00008165749,0.01732091,0.00005378491,0.0002645483,0.0000532919,0.0002486093,0.00178677,0.003410911,0.04778835,0.9288966],"study_design_scores_gemma":[0.0000103012,0.00004948693,0.0002763041,0.002974926,0.00007304946,0.0007628515,0.00003344116,0.00004662853,0.0006032471,0.001209874,0.9939494,0.00001045548],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001851332,0.9958163,0.0001448614,0.0004633683,0.0003517576,0.00001007273,0.00004643092,0.00001261227,0.002969471],"genre_scores_gemma":[0.001252739,0.9964734,0.0001949858,0.0003110069,0.0002675264,0.00001008022,0.00006538715,0.000002350912,0.001422508],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.008651671,"threshold_uncertainty_score":0.0289427,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1969226240","doi":"10.1517/13543776.12.8.1237","title":"Novel therapeutic strategies for impaired endothelium-dependent vascular relaxation","year":2002,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Eicosanoids and Hypertension Pharmacology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Endothelium; Pharmacology; Medicine; Vascular smooth muscle; Endothelial dysfunction; Angiogenesis; Fibrinolysis; Angiotensin II; Platelet; Immunology; Internal medicine; Blood pressure","authors":[{"name":"Rui Wang","is_ca":true},{"name":"Joseph Fomusi Ndisang","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07753051824902753,"gpt":0.3153465721417966,"spread":0.2378160538927691,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006453032,0.0005352668,0.0008230135,0.0005609374,0.0002897757,0.0008950504,0.000832501,0.001063535,0.008504436],"category_scores_gemma":[0.000292269,0.0001343805,0.0005102102,0.0002839686,0.0005582367,0.0008278157,0.0005060903,0.001729975,0.001602685],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003816998,"about_ca_system_score_gemma":0.0003937319,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002218543,"about_ca_topic_score_gemma":0.0005269226,"domain_scores_codex":[0.9998344,0.0000512022,0.000009078784,0.00002584823,0.00003318611,0.00004631481],"domain_scores_gemma":[0.999907,0.00003193332,0.0000161055,0.000008358219,0.0000184604,0.00001808919],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001855903,0.0019351,0.0006844166,0.003715355,0.000192415,0.002890945,0.000345482,0.001503175,0.1911515,0.07042166,0.02511594,0.700188],"study_design_scores_gemma":[0.002737479,0.007596969,0.005088219,0.001466295,0.0005200402,0.008357381,0.0005227913,0.003802198,0.08223652,0.05334795,0.8342037,0.000120576],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.09006356,0.7340517,0.06441086,0.03498547,0.005418837,0.000858465,0.000516554,0.0006750106,0.06901963],"genre_scores_gemma":[0.384598,0.5332865,0.03612232,0.009691197,0.003885627,0.001050219,0.0007407023,0.00008506861,0.03054041],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.008504436,"threshold_uncertainty_score":0.02845019,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4398778278","doi":"10.1080/13543776.2024.2358818","title":"Type II &amp; III inhibitors of tropomyosin receptor kinase (Trk): a 2020–2022 patent update","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Protein Kinase Regulation and GTPase Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"TRIUMF; University of Alberta; University of British Columbia","funders":"","keywords":"Trk receptor; Tropomyosin; Receptor; Tropomyosin receptor kinase A; Chemistry; Tropomyosin receptor kinase C; Kinase; Biochemistry; Pharmacology; Cell biology; Biology; Platelet-derived growth factor receptor; Neurotrophin","authors":[{"name":"Petar Iliev","is_ca":true},{"name":"Carolin Jaworski","is_ca":true},{"name":"Carmen Wängler","is_ca":false},{"name":"Björn Wängler","is_ca":false},{"name":"Brent D. G. Page","is_ca":true},{"name":"Ralf Schirrmacher","is_ca":true},{"name":"Justin J. Bailey","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03968029780223813,"gpt":0.2999855850946541,"spread":0.2603052872924159,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000878465,0.0006418998,0.0007149847,0.001280865,0.0002918285,0.001607393,0.0008394399,0.001729875,0.03019616],"category_scores_gemma":[0.001177906,0.0001841331,0.0009555238,0.001199533,0.0003061027,0.00171657,0.0006211418,0.002175475,0.01296997],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000910341,"about_ca_system_score_gemma":0.001370531,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008655644,"about_ca_topic_score_gemma":0.002124422,"domain_scores_codex":[0.9996444,0.00004504383,0.00002397385,0.00003849564,0.0001700643,0.00007802421],"domain_scores_gemma":[0.9995329,0.0001038505,0.00009163493,0.00001382224,0.0001787602,0.00007905612],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001850871,0.00009752502,0.0001660405,0.002845567,0.00005490032,0.0005002766,0.00004858248,0.0002637232,0.005300895,0.005528953,0.3058717,0.6791368],"study_design_scores_gemma":[0.00004362069,0.0001258074,0.0002872731,0.0006564689,0.00004755173,0.0005357442,0.00001314703,0.00008449425,0.0006927986,0.001080451,0.9964235,0.000009051991],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.005814327,0.8138617,0.003894047,0.04050213,0.01856436,0.0003685637,0.003434999,0.0005358292,0.113024],"genre_scores_gemma":[0.02108198,0.8841814,0.003159877,0.01866883,0.007787176,0.0002257502,0.003849151,0.00009000197,0.06095579],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.03019616,"threshold_uncertainty_score":0.1010162,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2590797524","doi":"10.1080/13543776.2017.1296950","title":"Patent disclosure requirements for therapeutic antibody patents","year":2017,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Business; Antibody; Pharmacology; Medicine; Immunology","authors":[{"name":"Carmela De Luca","is_ca":false},{"name":"Anastassia Trifonova","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.6197336892953145,"gpt":0.4823808556046756,"spread":0.1373528336906388,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009971257,0.0005272974,0.001106944,0.003228128,0.0005817921,0.00283539,0.001817543,0.005046458,0.02260469],"category_scores_gemma":[0.03964463,0.0002620144,0.001289471,0.002674305,0.001613998,0.002800149,0.001123706,0.002870592,0.003494859],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002016072,"about_ca_system_score_gemma":0.006269772,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002582658,"about_ca_topic_score_gemma":0.001795447,"domain_scores_codex":[0.9879881,0.00326914,0.001588976,0.0008256047,0.005843628,0.0004845192],"domain_scores_gemma":[0.9597558,0.02899132,0.00614978,0.0007664009,0.004017354,0.0003194259],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001301645,0.00005589432,0.000698982,0.02218823,0.0001348096,0.0006501965,0.0002279031,0.0009870452,0.001228761,0.1655979,0.1125707,0.6955294],"study_design_scores_gemma":[0.00004912294,0.00008771496,0.002102161,0.01632673,0.0001460619,0.001575385,0.00008116123,0.0002115351,0.000876724,0.02370464,0.9548077,0.00003107881],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002162172,0.8701632,0.004774302,0.02750599,0.001777164,0.0002594269,0.001856449,0.00008168393,0.09141958],"genre_scores_gemma":[0.07153792,0.8857454,0.005636385,0.01456489,0.004097236,0.0005147375,0.002645612,0.00003577533,0.01522202],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02260469,"threshold_uncertainty_score":0.07562029,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2762459231","doi":"10.1080/13543776.2018.1388780","title":"Bill C-30: who wins and who loses in Canada’s pharmaceutical patent battles?","year":2017,"lang":"en","type":"editorial","venue":"Expert Opinion on Therapeutic Patents","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Calgary","funders":"","keywords":"Business; Patent analysis; Patent troll; Patent law; Law; Political science; Computer science; Intellectual property","authors":[{"name":"Aidan Hollis","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1481829467643043,"gpt":0.340395631864411,"spread":0.1922126851001068,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01755989,0.00318886,0.004335771,0.005674397,0.01014745,0.01616361,0.007937679,0.08582657,0.01493407],"category_scores_gemma":[0.07173857,0.001739115,0.003324377,0.004403349,0.009088782,0.006452271,0.002686168,0.05546615,0.007125523],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.03182857,"about_ca_system_score_gemma":0.05841027,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.1993058,"about_ca_topic_score_gemma":0.3948281,"domain_scores_codex":[0.9799137,0.002246966,0.001922871,0.001737801,0.01146261,0.002716041],"domain_scores_gemma":[0.9437668,0.0240914,0.002734772,0.001116056,0.02240325,0.005887659],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000005040503,0.000003176133,0.00001248755,0.00003580763,0.000004156102,0.00002879107,0.0000140636,0.000006912842,0.000005908725,0.0004076828,0.9984307,0.001045334],"study_design_scores_gemma":[0.00004951619,0.000007526611,0.0002903793,0.0006579472,0.00004600809,0.00006429541,0.0001407576,0.0000859173,0.00005103707,0.001919576,0.9966479,0.00003911834],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.00006315545,0.01241991,0.00009010532,0.4513887,0.5297101,0.00004110642,0.0002246003,0.00004392681,0.006018364],"genre_scores_gemma":[0.001482876,0.009604037,0.0002014246,0.3154482,0.6483722,0.00006777769,0.000102842,0.00007325434,0.02464749],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.9681714,"threshold_uncertainty_score":0.3962914,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4402118985","doi":"10.1080/13543776.2024.2400175","title":"Trends in covalent drug discovery: a 2020–23 patent landscape analysis focused on select covalent reacting groups (CRGs) found in FDA-approved drugs","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Click Chemistry and Applications","field":"Chemistry","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Xenon Pharmaceuticals (Canada)","funders":"","keywords":"Drug; Drug discovery; Covalent bond; Pharmacology; Business; Chemistry; Combinatorial chemistry; Medicine; Biochemistry; Organic chemistry","authors":[{"name":"Jan Felix Scholtes","is_ca":true},{"name":"Cristóbal Alhambra","is_ca":false},{"name":"Philip A. Carpino","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1111098228938742,"gpt":0.3708849694896212,"spread":0.259775146595747,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["bibliometrics"],"consensus_categories":[],"category_scores_codex":[0.00387222,0.0005382285,0.0007605503,0.009985997,0.0003349012,0.003691688,0.0005300127,0.0006962463,0.006266778],"category_scores_gemma":[0.006541192,0.0001764404,0.001206263,0.01398895,0.000355845,0.003075381,0.0006097264,0.0007277646,0.001416447],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00213934,"about_ca_system_score_gemma":0.002155732,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001717199,"about_ca_topic_score_gemma":0.003122755,"domain_scores_codex":[0.9977676,0.0002820228,0.000205808,0.0003605459,0.001172259,0.0002118026],"domain_scores_gemma":[0.9908408,0.003657068,0.002525418,0.0001471652,0.002481115,0.0003484285],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0007369469,0.000155261,0.04367272,0.007925998,0.0006831503,0.000772098,0.0003409268,0.002763613,0.0105151,0.01795324,0.04525986,0.8692212],"study_design_scores_gemma":[0.0001096941,0.002104974,0.2321269,0.006335217,0.002118917,0.004023384,0.001615781,0.01052357,0.01190989,0.01663542,0.7123148,0.0001814522],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.3022879,0.5512716,0.01262944,0.02263086,0.0006280537,0.0005362811,0.02878125,0.0007306456,0.08050402],"genre_scores_gemma":[0.6602387,0.292551,0.01251281,0.004381931,0.0008999747,0.0002460021,0.02034704,0.0001696942,0.008652815],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.990014,"threshold_uncertainty_score":0.02096444,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2027041011","doi":"10.1517/13543776.17.3.277","title":"Therapeutic advances in the treatment of osteoporosis","year":2007,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Bone health and treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"Osteoporosis; Medicine; Strontium ranelate; Anabolic Agents; Bisphosphonate; Teriparatide; Pharmacology; Intensive care medicine; Internal medicine; Bone mineral","authors":[{"name":"Julian Mathoo","is_ca":true},{"name":"Lisa Becker","is_ca":true},{"name":"Dinesh Kumbhare","is_ca":true},{"name":"Jonathan D. Adachi","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0757609616107818,"gpt":0.3858486133101487,"spread":0.3100876516993669,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001076106,0.0005770298,0.0008198771,0.001325406,0.0003888361,0.0009329448,0.0006366516,0.001258088,0.01338932],"category_scores_gemma":[0.001086,0.000140993,0.0006144406,0.001098386,0.0005497469,0.0009583648,0.0006469006,0.002129716,0.003281972],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005933472,"about_ca_system_score_gemma":0.0009925574,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006780237,"about_ca_topic_score_gemma":0.001488037,"domain_scores_codex":[0.9995255,0.000117046,0.00003751779,0.0000641846,0.000214307,0.00004131544],"domain_scores_gemma":[0.999587,0.0001595234,0.00006704191,0.00002276002,0.0001215569,0.00004206915],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002751546,0.0003131448,0.0003396666,0.00449751,0.00009798213,0.0006488183,0.00009773184,0.0003658855,0.007506832,0.01635394,0.03262137,0.936882],"study_design_scores_gemma":[0.000205621,0.0005775843,0.001327223,0.001347167,0.0001561541,0.0020101,0.00007442599,0.0002530202,0.002474157,0.0100531,0.981497,0.00002447684],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001508069,0.9724317,0.001801789,0.008314467,0.001110559,0.00003479999,0.00007299968,0.00003562212,0.01469008],"genre_scores_gemma":[0.01611303,0.9697121,0.003339701,0.003066101,0.002420231,0.00004727495,0.0001130611,0.000009893325,0.005178652],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01338932,"threshold_uncertainty_score":0.04479176,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4413414271","doi":"10.1080/13543776.2025.2548586","title":"Implementation and outcomes of China’s drug patent linkage system: lessons from international experience","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Business; Drug; Linkage (software); China; Pharmacology; Medicine; Process management; Public relations; Political science; Biology; Gene; Genetics","authors":[{"name":"Yu Chen","is_ca":false},{"name":"Xinjuan Liu","is_ca":false},{"name":"Suju Li","is_ca":false},{"name":"Zhenyu Xu","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.261692608842277,"gpt":0.3822294978361596,"spread":0.1205368889938826,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01013432,0.0002498452,0.0005174083,0.001651038,0.0004848988,0.001943277,0.0007081766,0.0006969984,0.002482643],"category_scores_gemma":[0.01290514,0.00009913789,0.000407277,0.003966072,0.0007711852,0.00158622,0.0007201452,0.0007716608,0.000176764],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004316892,"about_ca_system_score_gemma":0.01500884,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02725179,"about_ca_topic_score_gemma":0.03086211,"domain_scores_codex":[0.9955462,0.001640676,0.0004750762,0.0002742731,0.001697457,0.0003663141],"domain_scores_gemma":[0.9942541,0.002597746,0.0008931404,0.0001663497,0.001870135,0.000218604],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002661621,0.0002046686,0.02289968,0.01716689,0.0002695002,0.001266553,0.006001033,0.001228758,0.001385578,0.03147354,0.01898391,0.8988538],"study_design_scores_gemma":[0.0002269576,0.002112898,0.2565149,0.02122132,0.001148885,0.002233487,0.01063268,0.001455593,0.005427785,0.004511693,0.6943575,0.0001562857],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.243747,0.6519734,0.001165516,0.02137025,0.0006061287,0.0005306587,0.001226904,0.00005793171,0.07932235],"genre_scores_gemma":[0.6692408,0.3238055,0.001039005,0.002091098,0.000222807,0.0001074868,0.0005173872,0.00001436348,0.002961457],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02725179,"threshold_uncertainty_score":0.05418628,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2102449842","doi":"10.1517/13543776.10.5.675","title":"Tyrosine phosphatases: cellular functions and therapeutic potential","year":2000,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Smiths Detection (Canada)","funders":"","keywords":"Protein tyrosine phosphatase; Tyrosine; Tyrosine phosphorylation; Receptor tyrosine kinase; Phosphorylation; Protein phosphorylation; Biochemistry; Tyrosine kinase; SH2 domain; Platelet-derived growth factor receptor; Cell biology; Proto-oncogene tyrosine-protein kinase Src; Phosphatase; Chemistry; Biology; Signal transduction; Protein kinase A; Receptor; Growth factor","authors":[{"name":"Amy G Klann","is_ca":true},{"name":"Raymond A. Miller","is_ca":false},{"name":"Eric D. Norman","is_ca":true},{"name":"Eric Klann","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0197475529811363,"gpt":0.2656236591770438,"spread":0.2458761061959075,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007566581,0.0006418714,0.000787914,0.0006519501,0.0003173154,0.001395997,0.0004543558,0.001143383,0.003713944],"category_scores_gemma":[0.0005526967,0.0001541313,0.0003367478,0.0007160751,0.0007193273,0.001153459,0.0005999937,0.001821751,0.001646564],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007590146,"about_ca_system_score_gemma":0.0006226004,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003204064,"about_ca_topic_score_gemma":0.0004447297,"domain_scores_codex":[0.9997819,0.00004398798,0.00001493778,0.0000339468,0.00008618319,0.00003912413],"domain_scores_gemma":[0.9998544,0.00004227073,0.00002838074,0.0000102666,0.00003433242,0.00003028646],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006111116,0.0001626523,0.0005974208,0.003747205,0.00008493247,0.001311482,0.000135018,0.0008967809,0.0752115,0.03801025,0.02511998,0.8541116],"study_design_scores_gemma":[0.0001762178,0.000683601,0.00167345,0.0006602794,0.0001601651,0.006677677,0.0001295575,0.0005870847,0.02673659,0.0215282,0.9409521,0.0000350109],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004202279,0.9836357,0.001395783,0.00390366,0.0004657827,0.00001222854,0.00006665253,0.00003666663,0.006281339],"genre_scores_gemma":[0.05379323,0.9367281,0.001832495,0.001195965,0.0009920808,0.0000391228,0.0001378729,0.000009585883,0.005271646],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003713944,"threshold_uncertainty_score":0.01242435,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4412046485","doi":"10.1080/13543776.2025.2529217","title":"Recent advances in tropomyosin receptor kinase (TRK) inhibitors: a 2023–2024 patent landscape review","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta; University of British Columbia; McMaster University","funders":"","keywords":"Trk receptor; Kinase; Receptor; Pharmacology; Medicine; Chemistry; Internal medicine; Biochemistry","authors":[{"name":"Minh Thong Le","is_ca":true},{"name":"Elena Timakova","is_ca":true},{"name":"Ralf Schirrmacher","is_ca":true},{"name":"Justin J. Bailey","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.111938606311881,"gpt":0.3980883209426094,"spread":0.2861497146307284,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008353549,0.0007492229,0.0009874349,0.003074259,0.0002638909,0.001373781,0.0007190933,0.00118486,0.01357385],"category_scores_gemma":[0.001434768,0.0002222766,0.001019084,0.002963312,0.0002716263,0.001619395,0.0005597467,0.001274995,0.002955082],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008418615,"about_ca_system_score_gemma":0.001801836,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009816618,"about_ca_topic_score_gemma":0.002290696,"domain_scores_codex":[0.9996779,0.0000511368,0.0000400268,0.00004691029,0.0001404364,0.00004367452],"domain_scores_gemma":[0.9993011,0.0003321091,0.0001169975,0.00001111305,0.000199375,0.00003923221],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008733327,0.00005181668,0.0001218487,0.02764798,0.0001002393,0.0003254718,0.00007166069,0.0003867661,0.001461332,0.005291846,0.06001567,0.9044381],"study_design_scores_gemma":[0.00002428379,0.00009815388,0.0004322867,0.007994084,0.0001753875,0.0007000437,0.00004731241,0.00009191301,0.000278702,0.001670382,0.9884744,0.00001292473],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000313879,0.9935917,0.0002032561,0.001514558,0.0004579299,0.0000210623,0.0001247649,0.00001846695,0.003754311],"genre_scores_gemma":[0.001436306,0.9960283,0.0002211651,0.0007241623,0.0003019718,0.00001383995,0.0001154861,0.000003068178,0.001155652],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01357385,"threshold_uncertainty_score":0.04540908,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2179086760","doi":"10.1517/13543776.2016.1118062","title":"Evaluation of WO2015042088 A1 - a novel urea-based scaffold for TrkA inhibition","year":2015,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Nerve injury and regeneration","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Trk receptor; Tropomyosin receptor kinase A; Chemistry; Kinase; Pharmacology; Biochemistry; Receptor; Nerve growth factor; Biology","authors":[{"name":"Vadim Bernard‐Gauthier","is_ca":true},{"name":"Ralf Schirrmacher","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.4187022352765148,"gpt":0.4125667785736195,"spread":0.006135456702895337,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001856271,0.0004275864,0.0005199054,0.000474386,0.0001905348,0.0003644005,0.0003719091,0.0005021426,0.004507789],"category_scores_gemma":[0.0001981836,0.0001415707,0.0003576698,0.0003340107,0.0001318744,0.0003228838,0.0003133866,0.000720575,0.001211122],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000192061,"about_ca_system_score_gemma":0.0002762303,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006033303,"about_ca_topic_score_gemma":0.001729213,"domain_scores_codex":[0.9999089,0.00001130191,0.000006123997,0.00001679537,0.00003412807,0.00002276574],"domain_scores_gemma":[0.9999565,0.000003613244,0.0000078475,0.000002221943,0.00001062191,0.0000192256],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001654458,0.001947449,0.000434763,0.002956476,0.0001446409,0.001610681,0.0001751516,0.004842144,0.8376551,0.004980902,0.01496625,0.1286321],"study_design_scores_gemma":[0.002489361,0.03450868,0.008802995,0.0009156233,0.0004487267,0.002688019,0.0002927638,0.01726192,0.697059,0.002500928,0.2328176,0.0002143621],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8671173,0.04786119,0.01074831,0.001861586,0.001028164,0.001060864,0.004467996,0.000793431,0.06506118],"genre_scores_gemma":[0.9538014,0.02133102,0.005126844,0.0008730451,0.00009643304,0.0003322955,0.00234085,0.0000584471,0.01603958],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004507789,"threshold_uncertainty_score":0.01508003,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2124374772","doi":"10.1517/13543770802557740","title":"Non-antibiotic strategies for the prevention/treatment of<i>Clostridium difficile</i>infection","year":2008,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"National Research Council Canada; Institute for Biological Sciences","funders":"","keywords":"Clostridium difficile; Metronidazole; Medicine; Antibiotics; Vancomycin; Intensive care medicine; Enterocolitis; Diarrhea; Disease; Internal medicine; Microbiology; Bacteria; Biology; Staphylococcus aureus","authors":[{"name":"Rhonda KuoLee","is_ca":true},{"name":"Wangxue Chen","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1295508869388775,"gpt":0.37628800678545,"spread":0.2467371198465726,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008782365,0.0003645607,0.0005025908,0.0009716951,0.0003285357,0.0008557868,0.00084804,0.001113764,0.01627855],"category_scores_gemma":[0.001036191,0.00006600561,0.0004024517,0.0005413272,0.0005884178,0.0009612128,0.0004095669,0.0008065039,0.002245744],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004865139,"about_ca_system_score_gemma":0.0008063772,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002966605,"about_ca_topic_score_gemma":0.0007133228,"domain_scores_codex":[0.9996169,0.0001076802,0.000026647,0.00003478176,0.0001577024,0.00005630662],"domain_scores_gemma":[0.9993501,0.0002552472,0.0001576041,0.00003026007,0.0001488441,0.00005793593],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007101974,0.00110554,0.001423018,0.007413933,0.0001014543,0.002103046,0.0001710256,0.0003664661,0.03419147,0.02299866,0.03212717,0.8972881],"study_design_scores_gemma":[0.0009524551,0.004560632,0.008287109,0.004095406,0.0004279048,0.0103001,0.0006335305,0.000777363,0.04073088,0.02052112,0.9086507,0.00006279306],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.03127763,0.8861799,0.008739864,0.02360456,0.002469915,0.0002202505,0.0001603417,0.000117093,0.04723047],"genre_scores_gemma":[0.2453644,0.7094459,0.0128986,0.008042731,0.004215197,0.0002543755,0.0003096454,0.00003172441,0.01943734],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01627855,"threshold_uncertainty_score":0.05445713,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2013882224","doi":"10.1517/13543770802554275","title":"Recently patented agents with possible antipsychotic indication","year":2008,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University Health Network","funders":"","keywords":"Antipsychotic; Agonism; Medicine; Mechanism (biology); Pharmacology; Atypical antipsychotic; Pharmacodynamics; Antagonism; Mechanism of action; Psychiatry; Receptor; Schizophrenia (object-oriented programming); Biology; Internal medicine; Political science; Pharmacokinetics","authors":[{"name":"Roger S. McIntyre","is_ca":true},{"name":"Candy W. Y. Law","is_ca":true},{"name":"Mohammad Alsuwaidan","is_ca":true},{"name":"Hanna O. Woldeyohannes","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1228857204877622,"gpt":0.3569428553952568,"spread":0.2340571349074946,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001585258,0.0004221739,0.0009122546,0.005409024,0.000477618,0.001643605,0.0008861776,0.001099677,0.0168838],"category_scores_gemma":[0.004922254,0.0001332313,0.00127682,0.006345984,0.0005751119,0.001538575,0.0004095475,0.0006869111,0.001510936],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002397739,"about_ca_system_score_gemma":0.004893913,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005254199,"about_ca_topic_score_gemma":0.0115337,"domain_scores_codex":[0.9990165,0.0001624396,0.0002123629,0.00009694126,0.0004407951,0.00007099492],"domain_scores_gemma":[0.9965643,0.001680512,0.0009565611,0.00007896865,0.0006527097,0.00006698647],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008025883,0.0001245921,0.004415634,0.08373369,0.0007767614,0.007464266,0.000432205,0.0003589477,0.01100771,0.01269908,0.0403074,0.837877],"study_design_scores_gemma":[0.000342066,0.000415165,0.01114573,0.02371617,0.003980302,0.01184237,0.0003389349,0.0002756213,0.007997365,0.004793936,0.935088,0.00006423945],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.007231398,0.9591113,0.001087711,0.002637093,0.0005232827,0.0001462088,0.0015096,0.00004362164,0.02770979],"genre_scores_gemma":[0.07105055,0.9122425,0.005095822,0.002526047,0.001198439,0.0001325319,0.001846795,0.00001445523,0.005892829],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0168838,"threshold_uncertainty_score":0.0564819,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2117496910","doi":"10.1517/13543776.18.9.975","title":"Structural biology in the battle against BCR-Abl","year":2008,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"Vertex Pharmaceuticals; Bristol-Myers Squibb; Boehringer Ingelheim","keywords":"Imatinib; Chronic myelogenous leukemia; Tyrosine kinase; Drug resistance; ABL; Tyrosine-kinase inhibitor; Drug; Cancer research; Pharmacology; Medicine; Leukemia; Biology; Cancer; Immunology; Myeloid leukemia; Internal medicine; Receptor; Genetics","authors":[{"name":"Bhushan Nagar","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1027041500105693,"gpt":0.3470829673624465,"spread":0.2443788173518772,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005945479,0.0004563235,0.0005326096,0.0004397891,0.0005090255,0.001160321,0.0005765725,0.00124966,0.003998671],"category_scores_gemma":[0.0003430468,0.0001923362,0.0002690715,0.0005162907,0.001315003,0.002541868,0.0007265419,0.001868508,0.001787371],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00110865,"about_ca_system_score_gemma":0.0007575766,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003625638,"about_ca_topic_score_gemma":0.0005537503,"domain_scores_codex":[0.9998193,0.00004755914,0.000006994919,0.0000231224,0.00006283012,0.00004013431],"domain_scores_gemma":[0.9998717,0.00004775689,0.00002280798,0.000007438933,0.00002255736,0.00002771094],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00049046,0.0003328352,0.0006553982,0.00297578,0.00008680605,0.001026035,0.0005273402,0.01047913,0.2212748,0.3547658,0.03074126,0.3766444],"study_design_scores_gemma":[0.0002625815,0.001135495,0.0007609572,0.0003899719,0.00006930107,0.001933816,0.0004359239,0.004270314,0.06861318,0.1660326,0.75604,0.0000559695],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1127837,0.6472512,0.03328237,0.1045374,0.003135408,0.0001880402,0.0002921418,0.0005840674,0.09794561],"genre_scores_gemma":[0.4442028,0.4986894,0.01889162,0.01533066,0.001507127,0.0001204278,0.0002754836,0.00008645518,0.02089611],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003998671,"threshold_uncertainty_score":0.01337689,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4417222214","doi":"10.1080/13543776.2025.2602703","title":"Tricyclic boronic acids as broad-spectrum serine and metallo-β-lactamase inhibitors with <i>in vitro</i> activity against <i>Acinetobacter baumannii</i> : a patent evaluation (US 2025/0223303)","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Synthesis of β-Lactam Compounds","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Queen's University","keywords":"Scope (computer science); Context (archaeology); Serine; Tricyclic; Enzyme; Boronic acid","authors":[{"name":"Alen Krajnc","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07328824272488464,"gpt":0.3353653821753039,"spread":0.2620771394504193,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003821046,0.0002821917,0.0002921587,0.0002848922,0.00008619836,0.00056566,0.0004823515,0.0007545412,0.009270304],"category_scores_gemma":[0.0004082875,0.00008278907,0.000272769,0.0002798441,0.0001824597,0.0004433127,0.0002013773,0.0005371939,0.002274237],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003891453,"about_ca_system_score_gemma":0.00030493,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004855692,"about_ca_topic_score_gemma":0.001034764,"domain_scores_codex":[0.9998325,0.00003053297,0.000009008674,0.00002787721,0.00006944618,0.00003054765],"domain_scores_gemma":[0.9998782,0.00002427313,0.00003637545,0.000003524827,0.00004325937,0.00001435806],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001342823,0.0002439682,0.000785554,0.009277241,0.0001749552,0.001613365,0.000118127,0.002070039,0.1058021,0.00865285,0.1150732,0.7548457],"study_design_scores_gemma":[0.0004155433,0.002142107,0.00174427,0.001906823,0.0002312205,0.003647237,0.0001905548,0.002168632,0.06550014,0.003413706,0.9185678,0.00007201076],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.05370104,0.8485493,0.00685622,0.01526288,0.003857737,0.0002045779,0.001796491,0.0002509861,0.06952086],"genre_scores_gemma":[0.263734,0.682687,0.003937123,0.009287132,0.002645123,0.000103443,0.001788988,0.00003409158,0.03578297],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.009270304,"threshold_uncertainty_score":0.0310123,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4256674571","doi":"10.1517/eotp.13.7.979.22985","title":"Epilepsy drug review: patent activity from 1999 to 2002","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Drug; Epilepsy; Pharmacology; Drug development; Medicine; Business; Psychiatry","authors":[{"name":"Mark R. Bowlby","is_ca":true},{"name":"Wayne E. Childers","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1706224520878894,"gpt":0.3322660331660597,"spread":0.1616435810781704,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["bibliometrics"],"consensus_categories":[],"category_scores_codex":[0.001508215,0.0004944347,0.0009419167,0.006702876,0.0002309656,0.001524656,0.0004223305,0.0009140225,0.005199338],"category_scores_gemma":[0.006555713,0.0001780035,0.0006363277,0.0127346,0.0002510455,0.001355701,0.0003699074,0.0005141189,0.001401165],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002092042,"about_ca_system_score_gemma":0.003336386,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003798485,"about_ca_topic_score_gemma":0.01015838,"domain_scores_codex":[0.999186,0.0001404651,0.0001373355,0.00009756637,0.0003656934,0.00007297613],"domain_scores_gemma":[0.9959494,0.00144889,0.001295042,0.00005390156,0.00113817,0.0001146588],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0004952597,0.00006418216,0.0009763709,0.02322905,0.0002886428,0.0004252454,0.00007159204,0.0006355737,0.0009225125,0.004546737,0.1631273,0.8052175],"study_design_scores_gemma":[0.00007324914,0.0001516896,0.008658006,0.005916786,0.0005813882,0.0008130299,0.00004834741,0.0001567557,0.0005357859,0.0008094668,0.9822416,0.00001371579],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.00245915,0.9830961,0.0002079698,0.003268372,0.0008431852,0.00003073567,0.0009426841,0.00001955924,0.009132229],"genre_scores_gemma":[0.01272358,0.9793969,0.0004627029,0.001508402,0.001056197,0.00002535176,0.0007152567,0.000005941732,0.004105766],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.9932971,"threshold_uncertainty_score":0.01739353,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2162925667","doi":"10.1517/13543776.13.7.979","title":"Epilepsy drug review: patent activity from 1999 to 2002","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Epilepsy; Drug; Anticonvulsant; Anticonvulsant drugs; Medicine; Action (physics); Pharmacology; Psychiatry","authors":[{"name":"Mark R. Bowlby","is_ca":true},{"name":"Wayne E. Childers","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1070106361356666,"gpt":0.3617737780236091,"spread":0.2547631418879425,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008636831,0.00060028,0.0009052318,0.004687868,0.0002708345,0.001334368,0.0004571248,0.0009371489,0.006236558],"category_scores_gemma":[0.00292413,0.0001530251,0.0005642507,0.006296632,0.0002339428,0.001458551,0.0004216758,0.0006294759,0.002197004],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001317005,"about_ca_system_score_gemma":0.001998718,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00194081,"about_ca_topic_score_gemma":0.005935668,"domain_scores_codex":[0.9995054,0.00006949632,0.00008138716,0.00005969513,0.000231211,0.00005292576],"domain_scores_gemma":[0.9985538,0.0004330204,0.0004397862,0.00002262052,0.0004833322,0.00006741574],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003902394,0.00007185146,0.0004020648,0.01375311,0.0001418118,0.0006591445,0.00006880972,0.0002846806,0.002484075,0.002189148,0.1082372,0.8713177],"study_design_scores_gemma":[0.00006400611,0.0002101449,0.003356421,0.002962382,0.0003650784,0.0014833,0.00004168617,0.00009215289,0.001151767,0.000527929,0.9897318,0.00001326518],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002803437,0.9795981,0.0003017311,0.002564971,0.001289557,0.00004390083,0.0005313681,0.00002983573,0.01283711],"genre_scores_gemma":[0.01178871,0.9750836,0.0007856722,0.002032879,0.001429807,0.00003556281,0.0007245946,0.000009119854,0.008110092],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006236558,"threshold_uncertainty_score":0.02086335,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4235008009","doi":"10.1517/eotp.13.10.1491.22914","title":"Therapeutic patents for the treatment of premenstrual syndrome and premenstrual dysphoric disorder: historical perspectives and future directions","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Therapeutic Patents","topic":"Menstrual Health and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Premenstrual dysphoric disorder; Etiology; Serotonergic; Medicine; Psychiatry; Physiology; Psychology; Hormone; Internal medicine; Serotonin; Menstrual cycle; Receptor","authors":[{"name":"Lori E. Ross","is_ca":true},{"name":"Meir Steiner","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.058909408830325,"gpt":0.3306736624273774,"spread":0.2717642535970525,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001858168,0.0005813922,0.000778248,0.001678746,0.0006320766,0.001880261,0.0007934425,0.00266927,0.01215858],"category_scores_gemma":[0.001943821,0.0001884574,0.0005304132,0.001382034,0.001145284,0.003623517,0.0006129865,0.001981345,0.001980342],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001170498,"about_ca_system_score_gemma":0.0009127085,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000563297,"about_ca_topic_score_gemma":0.001259881,"domain_scores_codex":[0.9995666,0.0001386332,0.00003813318,0.00006192898,0.0001288341,0.00006587629],"domain_scores_gemma":[0.9985343,0.0009275617,0.0001798666,0.00004628141,0.0002208944,0.00009103417],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.0003460328,0.0002761744,0.0004982468,0.002726091,0.00004603073,0.002072709,0.0002211648,0.0006942709,0.00387502,0.05969539,0.04095704,0.8885918],"study_design_scores_gemma":[0.0002004369,0.0007868332,0.0009522498,0.001913521,0.00008419237,0.005555913,0.0003254994,0.0005595516,0.002041935,0.03325181,0.9542896,0.00003857524],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002802747,0.9482893,0.002255948,0.01942533,0.001182419,0.00003759382,0.00006090404,0.00004742764,0.02589821],"genre_scores_gemma":[0.03009886,0.9456255,0.004509737,0.007962425,0.004118132,0.00008611527,0.00008901289,0.00001827943,0.007491842],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01215858,"threshold_uncertainty_score":0.04067445,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4403781693","doi":"10.1080/13543776.2024.2423023","title":"Ectonucleotidase inhibitors: an updated patent review (2017–2023)","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval","funders":"","keywords":"Chemistry; Pharmacology; Medicine","authors":[{"name":"Jamshed Iqbal","is_ca":false},{"name":"Sehrish Bano","is_ca":false},{"name":"Imtiaz Khan","is_ca":false},{"name":"Jean Sévigny","is_ca":true},{"name":"Qing Huang","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1443363722778405,"gpt":0.3912386502507594,"spread":0.2469022779729189,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004096544,0.0006536128,0.0008759024,0.001388023,0.0002300296,0.001085888,0.0006345405,0.001026499,0.02724916],"category_scores_gemma":[0.0006610951,0.0001958208,0.0007943739,0.001353763,0.0001881059,0.001053546,0.0004482883,0.001476518,0.008883144],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004971464,"about_ca_system_score_gemma":0.001003894,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007164621,"about_ca_topic_score_gemma":0.00155102,"domain_scores_codex":[0.9997934,0.00002340818,0.00001955387,0.00003307253,0.00009201781,0.0000386733],"domain_scores_gemma":[0.9998252,0.00004306316,0.00003884486,0.000004808056,0.00006647863,0.00002167352],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001923132,0.00009952739,0.0001344838,0.01325084,0.0001241473,0.0005129711,0.00006119361,0.0003603848,0.005796674,0.004864255,0.139706,0.8348971],"study_design_scores_gemma":[0.00004434551,0.0001548389,0.0004086422,0.001300206,0.0001233863,0.0008176543,0.00001758655,0.00006656961,0.0007931049,0.00083964,0.995419,0.00001507908],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001773251,0.9689061,0.0009860161,0.002868156,0.00287574,0.00009859187,0.001115778,0.0001111298,0.02126514],"genre_scores_gemma":[0.00662819,0.9738073,0.0008468959,0.002273776,0.001130558,0.00007004717,0.001467489,0.00001817892,0.01375764],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02724916,"threshold_uncertainty_score":0.0911575,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}